Saturday 17 October 2026
Export BDX’s income statement to Excel — free account
Becton, Dickinson and Company
BDX Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.
191.75
2.01
−1.04%
Follow BDX
| Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | Sep '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
30.03 | 31.56 | 413.84 | 48.99 | 64.89 | 27.29 | 29.59 | 40.61 | 31.86 | 25.20 |
Piotroski F-Score |
— | 5 | 4 | 7 | 5 | 7 | 5 | 5 | 6 | 7 |
Altman Z-Score |
2.44 | 2.22 | 1.66 | 1.84 | 1.74 | 1.99 | 1.99 | 2.25 | 1.97 | 1.84 |
P/S ratio |
2.35 | 2.73 | 3.28 | 3.03 | 3.10 | 2.85 | 2.65 | 2.99 | 2.72 | 1.94 |
Altman Z″-Score (non-manufacturers) |
2.95 | 4.61 | 1.64 | 1.89 | 2.09 | 2.21 | 2.22 | 2.49 | 2.24 | 2.29 |
P/FCF ratio |
15.71 | 18.08 | 26.59 | 22.07 | 22.96 | 18.60 | 33.33 | 27.42 | 17.61 | 15.85 |
P/Operating CF |
41.59 | 29.27 | 40.11 | 38.20 | 56.64 | 64.85 | 51.31 | 43.78 | 46.62 | 22.86 |
Beneish M-Score |
(2.80) | (2.72) | (1.95) | (2.67) | (2.60) | (2.73) | (2.59) | (2.43) | (2.57) | (2.64) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 67 |
P/B ratio |
3.84 | 2.55 | 2.50 | 2.48 | 2.10 | 2.30 | 1.98 | 2.25 | 2.12 | 1.67 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.04 | 3.10 | 4.38 | 4.04 | 3.99 | 3.62 | 3.32 | 3.68 | 3.50 | 2.71 |
EV/EBITDA |
14.92 | 14.34 | 20.08 | 17.40 | 21.17 | 15.45 | 13.88 | 16.20 | 15.06 | 11.74 |
EV/Operating CF |
14.84 | 14.68 | 24.44 | 20.97 | 21.82 | 16.78 | 25.35 | 23.83 | 18.36 | 17.25 |
EV/FCF |
20.35 | 20.53 | 35.55 | 29.43 | 29.55 | 23.62 | 41.82 | 33.68 | 22.62 | 22.16 |
Quick Ratio |
0.80 | 4.77 | 0.50 | 0.52 | 0.91 | 0.72 | 0.43 | 0.61 | 0.60 | 0.46 |
Current Ratio |
1.45 | 5.58 | 1.03 | 1.18 | 1.54 | 1.33 | 1.04 | 1.31 | 1.17 | 1.11 |
Net Debt/EBITDA |
3.40 | 1.71 | 5.06 | 4.35 | 4.72 | 3.28 | 2.82 | 3.01 | 3.34 | 3.33 |
Debt/Assets |
41.23% | 49.47% | 35.05% | 34.93% | 31.89% | 31.76% | 26.23% | 27.92% | 31.32% | 31.85% |
Debt/Equity |
1.38 | 1.44 | 0.90 | 0.86 | 0.72 | 0.72 | 0.55 | 0.57 | 0.69 | 0.69 |
Asset Turnover |
0.48 | 0.38 | 0.35 | 0.33 | 0.30 | 0.35 | 0.35 | 0.37 | 0.37 | 0.39 |
Operating CF/Net income |
2.62 | 2.48 | 18.02 | 3.08 | 3.83 | 2.06 | 1.46 | 2.10 | 2.25 | 2.04 |
Capex/Depreciation |
(0.62) | (0.67) | (0.45) | (0.42) | (0.36) | (0.54) | (0.44) | (0.38) | (0.32) | (0.31) |
Interest Coverage |
3.69 | 2.92 | 2.14 | 2.75 | 1.73 | 4.80 | 5.74 | 4.67 | 4.54 | 4.21 |
| 13.19% | 10.01% | 0.94% | 5.14% | 3.42% | 8.44% | 6.90% | 5.58% | 6.60% | 6.54% | |
| 3.75% | 3.25% | 0.35% | 2.05% | 1.45% | 3.71% | 3.16% | 2.69% | 3.10% | 2.98% | |
ROIC |
5.49% | 5.46% | 2.44% | 2.85% | 1.50% | 3.67% | 3.75% | 3.38% | 3.61% | 3.82% |
Return on Tangible Assets |
16.63% | 5.17% | 2.85% | 16.23% | 8.47% | 24.37% | 26.63% | 16.57% | 20.46% | 21.14% |
Average Days of Receivables |
47.31 | 52.64 | 52.96 | 49.50 | 54.45 | 44.84 | 42.38 | 47.74 | 54.86 | 50.04 |
Research and Development Expense of Revenue |
6.63% | 6.37% | 6.28% | 6.14% | 6.46% | 6.69% | 6.66% | 6.39% | 5.90% | 5.79% |
Selling, General and Administrative Expense of Revenue |
24.07% | 24.06% | 25.13% | 25.05% | 26.04% | 24.67% | 24.95% | 24.36% | 24.07% | 24.17% |
Intangible Assets out of Total Assets |
0.54 | 0.36 | 0.74 | 0.74 | 0.69 | 0.68 | 0.70 | 0.67 | 0.65 | 0.65 |
Share Based Compensation of Revenue |
1.57% | 1.44% | 2.01% | 1.51% | 1.47% | 1.20% | 1.23% | 1.34% | 1.22% | 1.18% |
Graham Net Nets |
(0.40) | (0.19) | (0.49) | (0.46) | (0.43) | (0.39) | (0.39) | (0.32) | (0.38) | (0.49) |
Graham Number |
60.88 | 79.66 | 29.93 | 83.41 | 72.60 | 112.80 | 108.70 | 100.58 | 109.37 | 107.70 |
Earnings Yield |
3.33% | 3.17% | 0.24% | 2.04% | 1.54% | 3.67% | 3.38% | 2.46% | 3.14% | 3.97% |
Free Cash Flow Yield |
6.36% | 5.53% | 3.76% | 4.53% | 4.35% | 5.38% | 3.00% | 3.65% | 5.68% | 6.31% |
Revenue per Share |
58.69 | 55.23 | 61.86 | 64.05 | 57.62 | 66.13 | 66.21 | 67.67 | 69.64 | 75.93 |
Operating CF per Share |
12.03 | 11.65 | 11.09 | 12.34 | 10.53 | 14.26 | 8.67 | 10.44 | 13.27 | 11.92 |
Capex per Share |
(3.26) | (3.32) | (3.46) | (3.55) | (2.76) | (4.13) | (3.41) | (3.05) | (2.50) | (2.64) |
Free Cash Flow per Share |
8.77 | 8.33 | 7.63 | 8.79 | 7.77 | 10.14 | 5.26 | 7.39 | 10.76 | 9.28 |
Cash per Share |
8.97 | 64.86 | 4.85 | 2.30 | 10.53 | 8.31 | 4.09 | 5.20 | 7.94 | 2.99 |
Shareholders Equity per Share |
35.89 | 59.14 | 81.26 | 78.09 | 85.19 | 81.85 | 88.71 | 90.11 | 89.35 | 88.27 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
35.89 | 59.14 | 81.26 | 78.09 | 85.19 | 81.85 | 88.71 | 90.11 | 89.35 | 88.27 |
Free Cash Flow |
1,866.00 | 1,823.00 | 1,970.00 | 2,373.00 | 2,168.00 | 2,932.00 | 1,498.00 | 2,116.00 | 3,119.00 | 2,670.00 |
Working Capital |
1,967.00 | 15,291.00 | 195.00 | 1,009.00 | 3,133.00 | 2,212.00 | 330.00 | 2,035.00 | 1,512.00 | 942.00 |
Capital Expenditures |
(693.00) | (727.00) | (895.00) | (957.00) | (769.00) | (1,194.00) | (973.00) | (874.00) | (725.00) | (760.00) |
Net Current Asset Value |
(11,586.00) | (6,153.00) | (25,499.00) | (24,020.00) | (21,278.00) | (21,351.00) | (19,511.00) | (18,308.00) | (20,928.00) | (20,680.00) |
EV/EBIT |
26.55 | 24.59 | 46.41 | 39.68 | 70.25 | 30.76 | 27.44 | 33.76 | 29.42 | 22.95 |
Capex to Sales |
0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.05 | 0.05 | 0.04 | 0.03 |
Price to Operating Income |
20.50 | 21.66 | 34.72 | 29.76 | 54.59 | 24.23 | 21.87 | 27.48 | 22.90 | 16.42 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.29 | 0.23 | 0.37 | 0.40 | 0.36 | 0.37 | 0.37 | 0.35 | 0.34 | 0.35 |
Cash ROIC |
9.29% | 3.98% | 4.79% | 5.97% | 4.94% | 6.79% | 3.71% | 5.04% | 6.76% | 6.09% |
Accounts Receivable Turnover |
7.72 | 7.19 | 7.87 | 7.41 | 6.78 | 8.06 | 8.31 | 8.20 | 7.25 | 7.25 |
Accounts Payable Turnover |
10.02 | 8.38 | 9.16 | 8.19 | 7.58 | 6.79 | 6.05 | 6.71 | 6.25 | 6.16 |
Inventory Turnover |
3.53 | 3.47 | 4.08 | 3.58 | 3.49 | 3.83 | 3.48 | 3.45 | 3.11 | 3.08 |
Average Days of Payables |
37.39 | 47.47 | 46.33 | 44.28 | 53.32 | 60.45 | 59.67 | 53.47 | 62.61 | 60.47 |
Days of Inventory on Hand |
96.65 | 108.28 | 102.66 | 104.57 | 107.93 | 95.35 | 113.23 | 106.65 | 126.91 | 119.29 |
Average Receivables |
1,618.00 | 1,681.00 | 2,031.50 | 2,332.00 | 2,371.50 | 2,374.00 | 2,270.50 | 2,362.50 | 2,783.50 | 3,013.50 |
Average Payables |
648.00 | 731.00 | 951.50 | 1,099.00 | 1,223.50 | 1,547.00 | 1,719.00 | 1,670.00 | 1,768.50 | 1,935.00 |
Average Inventory |
1,839.00 | 1,768.50 | 2,134.50 | 2,515.00 | 2,661.00 | 2,743.00 | 2,983.50 | 3,248.50 | 3,558.00 | 3,868.50 |
Average Assets |
26,032.00 | 31,660.00 | 45,819.00 | 52,834.50 | 52,888.50 | 53,939.00 | 53,400.00 | 52,857.00 | 55,033.00 | 56,305.50 |
Average Common Equity |
7,399.50 | 10,290.00 | 16,969.00 | 21,036.00 | 22,421.50 | 23,719.00 | 24,477.50 | 25,538.50 | 25,843.00 | 25,639.50 |
Columns are period end dates